스킵네비게이션

Enterprise Together with KSC

Company Overview
Our breast cancer diagnostic kit, DxMeⓇ BC Kit, measures a specific protein biomarker from the blood by ELISA regardless of breast & breast cancer characteristics. It can be used for the early detection of breast cancer.

Sectors

  • Medical Biotechnology (In vitro diagnostic medical device)

Project Summary

  • Blood-based breast cancer in vitro diagnostic kit in ELISA format

Business Model

  • Revenue model DxMeⓇ BC Kit,
  • Key Customer Hospitals, examination centers and companies of related field.
Major Performance

  • Sales

    • 2018-$298,182
    • 2019-$14,546

  • Investment

    • Cumulative
    • Investment Amount
    • $10,515,175

  • Employees

    • 2018-11
    • 2019-18
    • 2020-20

  • Patent

    • Domestic PCT 4
Overseas Expansion

Stage

  • Preparing for entering overseas
  • markets, and generating sales

Status

  • Malaysia: Completion of approval and preparation for product x-evaluation by local partner
  • USA: LDT Service preparation in progress
  • Netherlands: Preparation for product x-evaluation by local partner
  • Serbia: Medical device approval

Performance

  • Overseas sales in 2018 and 2019: Malaysia
  • Poster presented in international conferences : ASCO(2020), SABCS(2020)
  • Product Approval & Registration in Malaysia(IVDC6564821-54605)
Short-term goals in three years
  • We plan to achieve meaningful sales by finally signing an exclusive sales contract with our existing partners for overseas expansion. Also, set a quarterly sales target and increase the credibility of our breast cancer in vitro diagnostic kit by selling to existing partners. Considering this as an opportunity to promote the company worldwide, and we plan to develop additional business routes. In addition, if the entry into the Israel Market is successfully completed, we will plan intensive sales activities and achieve incremental goals.
Products / Services
1 3
Target Country
Israel
Date of Establishment
Nov 08, 2013
  • CEO
    Kyoung-hoon, Suh
  • Founder’s Background
    • E&S Healthcare Co., Ltd. , Chief Executive Officer(2013~ )
    • Pai Chai University, Professor Dept. of Biotechnology(1997~2021)
    • University of Illinois at Chicago Physiological Biochemistry(Ph.D)(1985~1992)
    • University of Chicago Post Doctoral Fellow(1992~1995)
    • Yonsei University, Dept. of Biochemistry(B.S & M.S)(1977~1983
목록